NetraMark Holdings Inc. (CSE: AIAI)
Canada
· Delayed Price · Currency is CAD 0.930
+0.080 (9.41%)
Dec 20, 2024, 2:12 PM EST
NetraMark Holdings Company Description
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.
Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas.
The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.
NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
NetraMark Holdings Inc.
| Country | Canada |
| Founded | 2016 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | George Achilleos |
Contact Details
Address: 1655 Dupont Street Toronto, British Columbia M6P 3T1 Canada | |
| Phone | 403-681-2549 |
| Website | netramark.com |
Stock Details
| Ticker Symbol | AIAI |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| George Achilleos | Chief Executive Officer and Director |
| Josh Spiegel | President |
| Daniel Gallucci | Founder, Chief Performance Officer and Director |
| Dr. Joseph Geraci Ph.D. | Founder, Chief Scientific and Technical Officer and Director |
| Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer |
| Jaime Hackett | Vice President of Marketing |
| Dr. Luca Pani M.D. | Chief Innovation and Regulatory Officer and Chief Medical Advisor |
| Dr. Kaveh Kavoosi | Head of Progressive Medicine |
| Dr. Larry Alphs | Chief Medical Officer and Member of Advisory Board |
| Dr. Angelico Carta M.D. | Chief Strategy Officer |